Skip to main content

Table 3 Efficacy of artesunate-amodiaquine or artemether-lumefantrine in ≥2 years old malarious children according to study site and year of enrolment

From: Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under

Site (Year)

PCR uncorrected

PCR corrected

ACPR_u

Failure_u

Total

ACPR_c

Recrudescence

Total

% Recrudescence

Artesunate-amodiaquine

 Ibadan (2005–2010)

15

0

15

15

0

15

-

 Damboa (2009–2010)

17

0

17

17

0

17

-

 Agbani (2009–2010)

23

5

28

23

4

27

14.8

 Makarfi (2009–2010)

17

0

17

17

0

17

-

 Ijede (2009–2010)

14

0

14

14

0

14

-

 Barkin Ladi (2009–2010)

15

3

18

15

0

15

-

 Ibadan (2011–2015)

11

0

11

11

0

11

-

 Total (2005–2015)

112

8

120

112

4

116

3.4

Artemether-lumefantrine

 Ibadan (2005–2010)

32

0

32

32

0

32

-

 Damboa (2009–2010)

7

0

7

7

0

7

-

 Agbani (2009–2010)

27

2

29

27

2

29

6.9

 Makarfi (2009–2010)

23

1

24

23

0

23

-

 Ijede (2009–2010)

13

1

14

13

0

13

-

 Barkin Ladi (2009–2010)

17

4

21

17

3

20

15

 Ibadan (2011–2015)

3

0

3

3

0

3

-

 Total (2005–2015)

122

8

130

122

5

127

3.9

  1. PCR polymerase chain reaction, ACPR_u adequate clinical and parasitological response uncorrected, ACPR_c adequate clinical and parasitological response corrected, Failure_u treatment failure uncorrected